drugset / Trial / NCT06406114

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

NCT06406114

RandomizedCrossoverQuadruple-blindDiagnostic

Summary

Cephalosporin antibiotics are commonly used but can result in allergic reactions and anaphylaxis. There is no clear diagnostic approach for cephalosporin-allergic patients, and guidance for the use of other antibiotics in allergic patients is based on side chain chemical similarity and limited skin testing evidence. This project includes a clinical trial and mechanistic studies to optimize the approach to cephalosporin allergy and advance future diagnostics.

Timeline

Start
2025-05-05
Primary completion
2028-07-01
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified
Subject Ampicillin Unknown 20 mg/ml Other
Subject Benzylpenicillin Unknown Other
Subject CEFACLOR ANHYDROUS Small molecule
Subject CEPHALEXIN ANHYDROUS Small molecule
Subject Cefadroxil Small molecule
Subject Cefazolin Small molecule 3.3 mg/ml Other
Subject Cefazolin Small molecule 33 mg/ml Other
Subject Cefazolin Small molecule 330 mg/ml Other
Subject Cefepime Small molecule 2 mg/ml Other
Subject Cefepime Small molecule 20 mg/ml Other
Subject Cefepime Small molecule 200 mg/ml Other
Subject Cefixime Other / unclassified
Subject Cefotaxime Small molecule Other
Subject Cefpodoxime Small molecule
Subject Ceftazidime Small molecule 1 mg/ml Other
Subject Ceftazidime Small molecule 10 mg/ml Other
Subject Ceftazidime Small molecule 100 mg/ml Other
Subject Ceftriaxone Other / unclassified 1 mg/ml Other
Subject Ceftriaxone Other / unclassified 10 mg/ml Other
Subject Ceftriaxone Other / unclassified 100 mg/ml Other
Subject Cefuroxime Small molecule 1 mg/ml Other
Subject Cefuroxime Small molecule 10 mg/ml Other
Subject Cefuroxime Small molecule 90 mg/ml Other
Subject PRE-PEN Unknown Other
Subject cefdinir Other / unclassified